Companies/Butterfly Network, Inc.

Company profile

Butterfly Network, Inc.

NYSE: BFLY · Healthcare · Medical - Devices

PublicHQ Guilford, CTCIK 0001804176Reports USD

#352 of 1,402 Healthcare companies by revenue65th-percentile growth

EA Score

61C

FH 59DQ 62GM 67SS 63

v0.1 · 65/100 weight · provisional

↑ filing timeliness, Altman-Z · ↓ listing tenure, disclosure history

Methodology →

Revenue TTM

$102.9M

Rev growth YoY (TTM)

+20.2%

Net income (FY)

-$77.1M

Employees

190

Market cap

$2.0B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$97.6M$97.6M2025

Net income-$77.1M-$77.1M2025

Operating income-$86.4M-$86.4M2025

Total assets$296.5M$296.5M2025

Liabilities$100.6M$100.6M2025

Equity$196.0M$196.0M2025

Revenue trend

FY2021 – FY2025 · USD

$27.6M

FY21

$46.3M

FY21

$62.6M

FY21

$73.4M

FY22

$65.9M

FY23

$82.1M

FY24

$97.6M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Product65%

Software And Other Services35%

By geography

UNITED STATES79%

Non-US21%

The read

Butterfly Network, Inc. booked $97.6M in FY2025 revenue, growing 19% year over year — faster than most Healthcare companies we track, at a -79.0% net margin.

Peers · Healthcare

Aurinia Pharmaceuticals Inc.77B+GeneDx Holdings Corp.64C Pulse Biosciences, Inc.43D Sionna Therapeutics, Inc.——

Key facts

CEOJoseph DeVivo

SectorHealthcare

IndustryMedical - Devices

HeadquartersGuilford, CT

ExchangeNYSE: BFLY

Employees190

IPO date2020-07-13

Latest filings

8-K2026-06-22 8-K2026-05-08 10-Q2026-04-30 8-K2026-04-30 DEF 14A2026-04-27 10-K2026-02-27 8-K2026-02-26 8-K2026-01-14

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.